Search - tctmd.com

Displaying 141 - 160 of 174

Sort: Relevancy | Date

Presentation TCT 2012

FAME 2 Cost-effectiveness: A Prospective, Randomized Trial Evaluating the Cost-effectiveness of FFR-Guided PCI in Patients with Stable Coronary Artery Disease

Presenter: William Fearon

October 24, 2012

News Conference News TCT 2012

PEACE: Data Demonstrate Benefits of Plaque Identification in High-Risk Patients

October 24, 2012

News Conference News TCT 2012

Paradigm Shift from Ischemia to Vulnerable Plaque Needed to Prevent Sudden Coronary Death

October 24, 2012

News Industry News

FFR-Guided PCI Demonstrates Cost-Effectiveness When Compared to Medical Therapy for Stable Coronary Artery Disease

October 24, 2012

News Conference News TCT 2012

FAME 2: FFR-Guided PCI Cost Effective vs. Medical Therapy

October 24, 2012

News Industry News

Data from FAME II Trial Concludes FFR-Guided PCI is Cost Effective and Improves Patient Outcomes

October 24, 2012

News Industry News

Volcano Announces Global Launch of PrimeWire Prestige® PLUS Pressure Guide Wire with AcuSense™ Technology

October 23, 2012

News Conference News TCT 2012

COURAGE, FAME: Revascularization More Effective Than OMT

October 22, 2012

News Industry News

Volcano to Highlight New Technologies and Clinical Study Results at TCT 2012

October 19, 2012

News Daily News

FAME Substudy: FFR-Guided PCI Just as Beneficial for Women as Men

October 17, 2012

News Conference News ESC 2012

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Caitlin E. Cox

September 04, 2012

News Conference News ESC 2012

FAME 2: PCI Bests Medical Therapy in Stable Patients with Proven Ischemia

August 28, 2012

News Conference News ESC 2012

Noninvasive CT-based FFR More Accurate than CT for Diagnosing Ischemic CAD

August 26, 2012

News Daily News

Perfusion Imaging Guidance for Revascularization Improves Outcomes

July 11, 2012

News Conference News EuroPCR 2012

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Caitlin E. Cox

May 22, 2012

News Conference News EuroPCR 2012

FAME II: FFR Pinpoints Stable CAD Patients Who Need PCI in Addition to Medical Therapy

Caitlin E. Cox

May 15, 2012

News Industry News

FAME II Trial Demonstrates FFR-Guided PCI Superior to Medical Treatment in Preliminary Findings

May 14, 2012

News Daily News

FFR Assessment for Small Vessel Disease Improves Outcomes

L.A. McKeown

March 23, 2012

News Industry News

Independent Data Safety Monitoring Board Recommends St. Jude Medical’s FAME II Clinical Trial Stop Enrollment Following Positive Interim Analysis

January 17, 2012

News Daily News

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

L.A. McKeown

December 08, 2011

Advertisement

FAME 2 Cost-effectiveness: A Prospective, Randomized Trial Evaluating the Cost-effectiveness of FFR-Guided PCI in Patients with Stable Coronary Artery Disease

PEACE: Data Demonstrate Benefits of Plaque Identification in High-Risk Patients

Paradigm Shift from Ischemia to Vulnerable Plaque Needed to Prevent Sudden Coronary Death

FFR-Guided PCI Demonstrates Cost-Effectiveness When Compared to Medical Therapy for Stable Coronary Artery Disease

FAME 2: FFR-Guided PCI Cost Effective vs. Medical Therapy

Data from FAME II Trial Concludes FFR-Guided PCI is Cost Effective and Improves Patient Outcomes

Volcano Announces Global Launch of PrimeWire Prestige® PLUS Pressure Guide Wire with AcuSense™ Technology

COURAGE, FAME: Revascularization More Effective Than OMT

Volcano to Highlight New Technologies and Clinical Study Results at TCT 2012

FAME Substudy: FFR-Guided PCI Just as Beneficial for Women as Men

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

FAME 2: PCI Bests Medical Therapy in Stable Patients with Proven Ischemia

Noninvasive CT-based FFR More Accurate than CT for Diagnosing Ischemic CAD

Perfusion Imaging Guidance for Revascularization Improves Outcomes

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

FAME II: FFR Pinpoints Stable CAD Patients Who Need PCI in Addition to Medical Therapy

FAME II Trial Demonstrates FFR-Guided PCI Superior to Medical Treatment in Preliminary Findings

FFR Assessment for Small Vessel Disease Improves Outcomes

Independent Data Safety Monitoring Board Recommends St. Jude Medical’s FAME II Clinical Trial Stop Enrollment Following Positive Interim Analysis

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content